Project
Shigellosis [30]
Project
GlycoShig1
Laurence Mulard
Patent
Protected tetrasaccharides, their preparation and their use in the synthesis of bacterial oligosaccharides
Laurence Mulard
Patent
Glycoconjugates and their use as potential vaccines against infection by Shigella flexneri (SF6)
Laurence Mulard
Patent
Glycoconjugates and use thereof as vaccines against Shigella flexneri serotype 3a and X
Laurence Mulard
Patent
Glycoconjugates and their use as potential vaccines against infection by Shigella flexneri
Laurence Mulard
Group
Group: Carbohydrates and Bioconjugates
Laurence Mulard
Project
A synthetic carbohydrate-based conjugate vaccine ready for a clinical trial
Laurence Mulard
Project
FlexBiVac
Laurence Mulard
Project
Exocytosis: inhibition of secretion/recycling by the pathogen Shigella
Nathalie Sauvonnet
Project
CarbUniVax
Laurence Mulard
Project
Pôle d’Identification Bactérienne (PIB)
Anne Le Fleche
Project
Bioinformatics of genome sequencing applied to epidemiological surveillance of infectious agents
Sylvain Brisse
Group
Group: Response to Infection in the Whole Organism
Jean-Pierre Levraud
Program Project
The institut Carnot Pasteur MS
Carnot, label of excellence Founded in 2006, the Carnot Label, granted by the French government, was designed to develop partnership-based research, meaning research conducted by public laboratories in partnership with socio-economic players, primarily industry […]
Technician